Playful Physical Activity for Executive Functions and School Readiness in Preschool Children (NCT07678294) | Clinical Trial Compass
CompletedNot Applicable
Playful Physical Activity for Executive Functions and School Readiness in Preschool Children
Tunisia48 participantsStarted 2025-04-07
Plain-language summary
Executive functions, such as attention, inhibition, working memory, and planning, are important for early learning and school readiness in preschool children. This completed randomized controlled trial evaluated whether an 8-week cognitively enriched playful physical activity program could support executive functions and school readiness in preschool children compared with the regular physical education curriculum.
Preschool children were assigned to either a playful physical activity intervention group or a control group receiving conventional physical education. The intervention included structured movement-based games designed to combine physical activity with cognitive challenges, including response inhibition, working memory, planning, rule following, and cooperative problem solving. Outcomes included measures of executive functions and school readiness domains, including mathematical, linguistic, and social competence.
Who can participate
Age range
55 Months – 64 Months
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Preschool children aged 55 to 64 months.
* Enrollment in one of the participating preschools.
* Ability to participate in age-appropriate physical activity sessions.
* Written informed consent provided by parents or legal guardians.
Exclusion Criteria:
* Motor or intellectual disabilities that could prevent participation in physical activity sessions.
* Diagnosed neurological, psychiatric, or developmental disorders, including attention-deficit/hyperactivity disorder or autism spectrum disorder.
* Uncorrected visual or auditory impairments that could affect test performance.
* Use of medication known to affect the central nervous system.
* Absence from post-intervention testing or failure to complete the study procedures.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in School Readiness Scores From Baseline to Post-intervention
Timeframe: Baseline and immediately after the 8-week intervention